$10.57
0.656.55%
Last update: Nov 11, 4:00 PM
Turn Therapeutics Inc
TTRXNASDAQ
Turn Therapeutics rose 172.4% from $3.88 to $10.57, ahead of the S&P 500's +11.2%. Its worst day was Dec 8 (−21.8%), and its low came Nov 20 at $2.71.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Turn Therapeutics closed at its lowest level of the year, 30.2% below where the year started.
−4.2% · S&P 500 −1.5%
Turn Therapeutics shares fell 21.8%, while the S&P 500 fell 0.3%.
−21.8%, the year's worst day · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
EPS of $0.01 was reported on $0.00 revenue.
−1.9% · S&P 500 +0.8%
EPS of $-0.03 missed the $-0.02 estimate on $0.00 revenue.
+2.6% · S&P 500 −0.2%
92.6% of GX-03-treated subjects achieved a 50% reduction in eczema severity in 4 weeks (EASI-50); 70.4% achieved a 75% reduction in 4 weeks (EASI-75); 44.4% achieved a 90% reduction in 4 weeks (EASI-90); and 51.9%
+21.7% · S&P 500 +0.3%
Turn Therapeutics shares rose 26.3%, while the S&P 500 fell 0.5%.
+26.3% · S&P 500 −0.5%
EPS of $-0.20 missed the $-0.02 estimate on $0.00 revenue.
−6.5% · S&P 500 +0.7%
Turn Therapeutics shares rose 29.2%, while the S&P 500 fell 0.5%.
+29.2%, the year's best day · S&P 500 −0.5%
Turn Therapeutics closed at its highest level of the year, 295.4% above where the year started.
+2.7% · S&P 500 +1.6%
EPS of $-0.21 missed the $-0.09 estimate on $0.00 revenue.
+3.3% · S&P 500 +2.4%
Where it ended: a close of $10.57 on Nov 11, 2026.
Nothing in the past 12 months.
All TTRX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TTRX and SPY from Benzinga historical bars. Not investment advice.
